Please wait while the formulary information is being retrieved.
PROSCAR (finasteride)
- enlarged prostate with urination problem
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
1 mg tablet
- 1 tablet (1 mg) by oral route once daily
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
1 mg tablet
- 1 tablet (1 mg) by oral route once daily
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
Default screening record
- 1 tablet (5 mg) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactation
- Pregnancy
Contraindicated
- Suicidal ideation
Severe
Moderate
- Disease of liver
- High-grade prostate cancer
- Malignant tumor of male breast
PROSCAR (finasteride)
- enlarged prostate with urination problem
- None
- Disorder of ejaculation
- Erectile dysfunction
- Gynecomastia
- Libido changes
- Mastalgia
More Frequent
Severe
Less Severe
- High-grade prostate cancer
- Hypersensitivity drug reaction
- Decrease ejaculate volume
- Hypotension
- Peripheral edema
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Angioedema
- Malignant tumor of male breast
- Rhabdomyolysis
- Seizure disorder
- Suicidal
- Suicidal ideation
- Urticaria
Less Severe
- Depression
- Hematospermia
- Muscle weakness
- Myalgia
- Myopathy
- Oligospermia
- Orgasm disorder
- Pruritus of skin
- Testicular pain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Finasteride
Not indicated in pediatrics. No safety and efficacy studies.
- 1 Day – 18 Years
- Not indicated in pediatrics. No safety and efficacy studies.
Finasteride
- Severity Level:
1
- Additional Notes: Contraindicated during pregnancy; may cause harm to male fetus
Contraindicated
Finasteride
Not indicated in women; potential for serious adverse effects in infant.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Not indicated in women; potential for serious adverse effects in infant. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Benign prostatic hyperplasia with lower urinary tract sx | |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
| 0-9 | A-Z |
|---|---|
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
Formulary Reference Tool